List of Tables
Table 1. Global Biosimilar and Biologics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Biosimilar and Biologics Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Biosimilar and Biologics Market Competitive Situation by Manufacturers in 2024
Table 4. Global Biosimilar and Biologics Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Biosimilar and Biologics Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Biosimilar and Biologics Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Biosimilar and Biologics Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Biosimilar and Biologics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Biosimilar and Biologics, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Biosimilar and Biologics, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Biosimilar and Biologics, Product Type & Application
Table 12. Global Key Manufacturers of Biosimilar and Biologics, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Biosimilar and Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biosimilar and Biologics as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Biosimilar and Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Biosimilar and Biologics Sales by Region (2020-2025) & (K Units)
Table 18. Global Biosimilar and Biologics Sales Market Share by Region (2020-2025)
Table 19. Global Biosimilar and Biologics Sales by Region (2026-2031) & (K Units)
Table 20. Global Biosimilar and Biologics Sales Market Share by Region (2026-2031)
Table 21. Global Biosimilar and Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Biosimilar and Biologics Revenue Market Share by Region (2020-2025)
Table 23. Global Biosimilar and Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Biosimilar and Biologics Revenue Market Share by Region (2026-2031)
Table 25. North America Biosimilar and Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Biosimilar and Biologics Sales by Country (2020-2025) & (K Units)
Table 27. North America Biosimilar and Biologics Sales by Country (2026-2031) & (K Units)
Table 28. North America Biosimilar and Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Biosimilar and Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Biosimilar and Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Biosimilar and Biologics Sales by Country (2020-2025) & (K Units)
Table 32. Europe Biosimilar and Biologics Sales by Country (2026-2031) & (K Units)
Table 33. Europe Biosimilar and Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Biosimilar and Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Biosimilar and Biologics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Biosimilar and Biologics Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Biosimilar and Biologics Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Biosimilar and Biologics Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Biosimilar and Biologics Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Biosimilar and Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Biosimilar and Biologics Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Biosimilar and Biologics Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Biosimilar and Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Biosimilar and Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Biosimilar and Biologics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Biosimilar and Biologics Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Biosimilar and Biologics Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Biosimilar and Biologics Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Biosimilar and Biologics Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Biosimilar and Biologics Sales (K Units) by Type (2020-2025)
Table 51. Global Biosimilar and Biologics Sales (K Units) by Type (2026-2031)
Table 52. Global Biosimilar and Biologics Sales Market Share by Type (2020-2025)
Table 53. Global Biosimilar and Biologics Sales Market Share by Type (2026-2031)
Table 54. Global Biosimilar and Biologics Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Biosimilar and Biologics Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Biosimilar and Biologics Revenue Market Share by Type (2020-2025)
Table 57. Global Biosimilar and Biologics Revenue Market Share by Type (2026-2031)
Table 58. Global Biosimilar and Biologics Price (US$/Unit) by Type (2020-2025)
Table 59. Global Biosimilar and Biologics Price (US$/Unit) by Type (2026-2031)
Table 60. Global Biosimilar and Biologics Sales (K Units) by Application (2020-2025)
Table 61. Global Biosimilar and Biologics Sales (K Units) by Application (2026-2031)
Table 62. Global Biosimilar and Biologics Sales Market Share by Application (2020-2025)
Table 63. Global Biosimilar and Biologics Sales Market Share by Application (2026-2031)
Table 64. Global Biosimilar and Biologics Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Biosimilar and Biologics Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Biosimilar and Biologics Revenue Market Share by Application (2020-2025)
Table 67. Global Biosimilar and Biologics Revenue Market Share by Application (2026-2031)
Table 68. Global Biosimilar and Biologics Price (US$/Unit) by Application (2020-2025)
Table 69. Global Biosimilar and Biologics Price (US$/Unit) by Application (2026-2031)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Pfizer Biosimilar and Biologics Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Roche AG Company Information
Table 76. Roche AG Description and Business Overview
Table 77. Roche AG Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Roche AG Biosimilar and Biologics Product
Table 79. Roche AG Recent Developments/Updates
Table 80. AbbVie Company Information
Table 81. AbbVie Description and Business Overview
Table 82. AbbVie Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. AbbVie Biosimilar and Biologics Product
Table 84. AbbVie Recent Developments/Updates
Table 85. Novartis AG Company Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Novartis AG Biosimilar and Biologics Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Merck Company Information
Table 91. Merck Description and Business Overview
Table 92. Merck Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Merck Biosimilar and Biologics Product
Table 94. Merck Recent Developments/Updates
Table 95. Bristol Myers Squibb Company Information
Table 96. Bristol Myers Squibb Description and Business Overview
Table 97. Bristol Myers Squibb Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Bristol Myers Squibb Biosimilar and Biologics Product
Table 99. Bristol Myers Squibb Recent Developments/Updates
Table 100. GSK Company Information
Table 101. GSK Description and Business Overview
Table 102. GSK Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. GSK Biosimilar and Biologics Product
Table 104. GSK Recent Developments/Updates
Table 105. AstraZeneca Company Information
Table 106. AstraZeneca Description and Business Overview
Table 107. AstraZeneca Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. AstraZeneca Biosimilar and Biologics Product
Table 109. AstraZeneca Recent Developments/Updates
Table 110. Eli Lilly Company Information
Table 111. Eli Lilly Description and Business Overview
Table 112. Eli Lilly Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Eli Lilly Biosimilar and Biologics Product
Table 114. Eli Lilly Recent Developments/Updates
Table 115. Bayer Company Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Bayer Biosimilar and Biologics Product
Table 119. Bayer Recent Developments/Updates
Table 120. Gilead Sciences Company Information
Table 121. Gilead Sciences Description and Business Overview
Table 122. Gilead Sciences Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Gilead Sciences Biosimilar and Biologics Product
Table 124. Gilead Sciences Recent Developments/Updates
Table 125. Amgen Company Information
Table 126. Amgen Description and Business Overview
Table 127. Amgen Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. Amgen Biosimilar and Biologics Product
Table 129. Amgen Recent Developments/Updates
Table 130. Boehringer Ingelheim Company Information
Table 131. Boehringer Ingelheim Description and Business Overview
Table 132. Boehringer Ingelheim Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. Boehringer Ingelheim Biosimilar and Biologics Product
Table 134. Boehringer Ingelheim Recent Developments/Updates
Table 135. Novo Nordisk Company Information
Table 136. Novo Nordisk Description and Business Overview
Table 137. Novo Nordisk Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Novo Nordisk Biosimilar and Biologics Product
Table 139. Novo Nordisk Recent Developments/Updates
Table 140. Viatris Company Information
Table 141. Viatris Description and Business Overview
Table 142. Viatris Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Viatris Biosimilar and Biologics Product
Table 144. Viatris Recent Developments/Updates
Table 145. Johnson Company Information
Table 146. Johnson Description and Business Overview
Table 147. Johnson Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Johnson Biosimilar and Biologics Product
Table 149. Johnson Recent Developments/Updates
Table 150. Sanofi Winthrop Industries Company Information
Table 151. Sanofi Winthrop Industries Description and Business Overview
Table 152. Sanofi Winthrop Industries Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Sanofi Winthrop Industries Biosimilar and Biologics Product
Table 154. Sanofi Winthrop Industries Recent Developments/Updates
Table 155. Serum Institute of India Company Information
Table 156. Serum Institute of India Description and Business Overview
Table 157. Serum Institute of India Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Serum Institute of India Biosimilar and Biologics Product
Table 159. Serum Institute of India Recent Developments/Updates
Table 160. Biocon Company Information
Table 161. Biocon Description and Business Overview
Table 162. Biocon Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Biocon Biosimilar and Biologics Product
Table 164. Biocon Recent Developments/Updates
Table 165. Intas Pharmaceuticals Company Information
Table 166. Intas Pharmaceuticals Description and Business Overview
Table 167. Intas Pharmaceuticals Biosimilar and Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Intas Pharmaceuticals Biosimilar and Biologics Product
Table 169. Intas Pharmaceuticals Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Biosimilar and Biologics Distributors List
Table 173. Biosimilar and Biologics Customers List
Table 174. Biosimilar and Biologics Market Trends
Table 175. Biosimilar and Biologics Market Drivers
Table 176. Biosimilar and Biologics Market Challenges
Table 177. Biosimilar and Biologics Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Biosimilar and Biologics
Figure 2. Global Biosimilar and Biologics Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Biosimilar and Biologics Market Share by Type: 2024 & 2031
Figure 4. Monoclonal Antibody Product Picture
Figure 5. Vaccines Product Picture
Figure 6. Recombinant Insulin Product Picture
Figure 7. Growth Factors Product Picture
Figure 8. Immune Modulators Product Picture
Figure 9. Fusion Protein Product Picture
Figure 10. Erythoprotein Product Picture
Figure 11. Other Product Picture
Figure 12. Global Biosimilar and Biologics Market Value by Application (2020-2031) & (US$ Million)
Figure 13. Global Biosimilar and Biologics Market Share by Application: 2024 & 2031
Figure 14. Autoimmune Diseases
Figure 15. Infectious Diseases
Figure 16. Cardiovascular Disorders
Figure 17. Other
Figure 18. Global Biosimilar and Biologics Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Biosimilar and Biologics Market Size (2020-2031) & (US$ Million)
Figure 20. Global Biosimilar and Biologics Sales (2020-2031) & (K Units)
Figure 21. Global Biosimilar and Biologics Average Price (US$/Unit) & (2020-2031)
Figure 22. Biosimilar and Biologics Report Years Considered
Figure 23. Biosimilar and Biologics Sales Share by Manufacturers in 2024
Figure 24. Global Biosimilar and Biologics Revenue Share by Manufacturers in 2024
Figure 25. Global 5 and 10 Largest Biosimilar and Biologics Players: Market Share by Revenue in Biosimilar and Biologics in 2024
Figure 26. Biosimilar and Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 27. Global Biosimilar and Biologics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 28. North America Biosimilar and Biologics Sales Market Share by Country (2020-2031)
Figure 29. North America Biosimilar and Biologics Revenue Market Share by Country (2020-2031)
Figure 30. United States Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Canada Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Europe Biosimilar and Biologics Sales Market Share by Country (2020-2031)
Figure 33. Europe Biosimilar and Biologics Revenue Market Share by Country (2020-2031)
Figure 34. Germany Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. France Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. U.K. Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Italy Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Russia Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Asia Pacific Biosimilar and Biologics Sales Market Share by Region (2020-2031)
Figure 40. Asia Pacific Biosimilar and Biologics Revenue Market Share by Region (2020-2031)
Figure 41. China Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Japan Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. South Korea Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. India Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Australia Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. China Taiwan Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Southeast Asia Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Latin America Biosimilar and Biologics Sales Market Share by Country (2020-2031)
Figure 49. Latin America Biosimilar and Biologics Revenue Market Share by Country (2020-2031)
Figure 50. Mexico Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Brazil Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Argentina Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Middle East and Africa Biosimilar and Biologics Sales Market Share by Country (2020-2031)
Figure 54. Middle East and Africa Biosimilar and Biologics Revenue Market Share by Country (2020-2031)
Figure 55. Turkey Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Saudi Arabia Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. UAE Biosimilar and Biologics Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. Global Sales Market Share of Biosimilar and Biologics by Type (2020-2031)
Figure 59. Global Revenue Market Share of Biosimilar and Biologics by Type (2020-2031)
Figure 60. Global Biosimilar and Biologics Price (US$/Unit) by Type (2020-2031)
Figure 61. Global Sales Market Share of Biosimilar and Biologics by Application (2020-2031)
Figure 62. Global Revenue Market Share of Biosimilar and Biologics by Application (2020-2031)
Figure 63. Global Biosimilar and Biologics Price (US$/Unit) by Application (2020-2031)
Figure 64. Biosimilar and Biologics Value Chain
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
